We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 501.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMDC
RNS Number : 0594H
Mediclinic International plc
02 June 2017
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")
2 June 2017
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Awards under the Company's Long-Term Incentive Plan
On 1 June 2017, awards over ordinary shares in Mediclinic (the "Shares") were granted to the following Directors and other persons discharging managerial responsibilities ("PDMRs") under the rules of the Company's Long-Term Incentive Plan (the "LTIP"), which was approved by shareholders in December 2015:
Name Director/ Number of Shares awarded PDMR under the LTIP ------------------ ----------- ------------------------- Danie Meintjes Director 129,626 ------------------ ----------- ------------------------- Jurgens Myburgh Director 65,263 ------------------ ----------- ------------------------- Dr Ronnie van der Merwe PDMR 26,898 ------------------ ----------- ------------------------- Gert Hattingh PDMR 26,898 ------------------ ----------- ------------------------- Dr Dirk le Roux PDMR 21,211 ------------------ ----------- ------------------------- Koert Pretorius PDMR 26,691 ------------------ ----------- ------------------------- David Hadley PDMR 18,397 ------------------ ----------- ------------------------- Dr Ole Wiesinger PDMR 22,350 ------------------ ----------- -------------------------
Nil consideration per share was paid for the grant of the awards, which are structured as conditional awards.
The vesting of an award is subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company. The awards for PDMRs will normally vest on the later of the third anniversary of grant, other than for those PDMRs who also sit on the Board of Directors of Mediclinic International PLC whose awards will vest on the later of the fifth anniversary of grant.
The following notification made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation relates to the Company's LTIP.
1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------- a) Name Daniël Petrus Meintjes --- --------------------- -------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------- a) Position Chief Executive Officer of the / status Company --- --------------------- -------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- -------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------- a) Name Mediclinic International plc --- --------------------- -------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- -------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------- a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- -------------------------------------- b) Nature of Award over ordinary shares in the transaction Mediclinic International plc granted under the Company's Long Term Incentive Plan --- --------------------- -------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) ---------- ---------- Nil cost 129,626 ---------- ---------- --- --------------------- -------------------------------------- d) Aggregated information Aggregated volume 129,626 Price ZAR0.00 --- --------------------- -------------------------------------- e) Date of the 1 June 2017 transaction --- --------------------- -------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- -------------------------------------- 1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------- a) Name Petrus Jurgens Myburgh --- --------------------- -------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------- a) Position Chief Financial Officer of the / status Company --- --------------------- -------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- -------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------- a) Name Mediclinic International plc --- --------------------- -------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- -------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------- a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- -------------------------------------- b) Nature of Award over ordinary shares in the transaction Mediclinic International plc granted under the Company's Long Term Incentive Plan --- --------------------- -------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) ---------- ---------- Nil cost 65,263 ---------- ---------- --- --------------------- -------------------------------------- d) Aggregated information Aggregated volume 65,263 Price ZAR0.00 --- --------------------- -------------------------------------- e) Date of the 1 June 2017 transaction --- --------------------- -------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- -------------------------------------- 1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------- a) Name Dr Carel A van der Merwe --- --------------------- -------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------- a) Position Chief Clinical Officer of the / status Company --- --------------------- -------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- -------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------- a) Name Mediclinic International plc --- --------------------- -------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- -------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------- a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- -------------------------------------- b) Nature of Award over ordinary shares in the transaction Mediclinic International plc granted under the Company's Long Term Incentive Plan --- --------------------- -------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) ---------- ----------
Nil cost 26,898 ---------- ---------- --- --------------------- -------------------------------------- d) Aggregated information Aggregated volume 26,898 Price ZAR0.00 --- --------------------- -------------------------------------- e) Date of the 1 June 2017 transaction --- --------------------- -------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- -------------------------------------- 1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------- a) Name Gert C Hattingh --- --------------------- -------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------- a) Position Chief Corporate Services Officer / status of the Company --- --------------------- -------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- -------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------- a) Name Mediclinic International plc --- --------------------- -------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- -------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------- a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- -------------------------------------- b) Nature of Award over ordinary shares in the transaction Mediclinic International plc granted under the Company's Long Term Incentive Plan --- --------------------- -------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) ---------- ---------- Nil cost 26,898 ---------- ---------- --- --------------------- -------------------------------------- d) Aggregated information Aggregated volume 26,898 Price ZAR0.00 --- --------------------- -------------------------------------- e) Date of the 1 June 2017 transaction --- --------------------- -------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- -------------------------------------- 1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------- a) Name Dr Dirk Cornelius le Roux --- --------------------- -------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------- a) Position Chief Information Officer of the / status Company --- --------------------- -------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- -------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------- a) Name Mediclinic International plc --- --------------------- -------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- -------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------- a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- -------------------------------------- b) Nature of Award over ordinary shares in the transaction Mediclinic International plc granted under the Company's Long Term Incentive Plan --- --------------------- -------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) ---------- ---------- Nil cost 21,211 ---------- ---------- --- --------------------- -------------------------------------- d) Aggregated information Aggregated volume 21,211 Price ZAR0.00 --- --------------------- -------------------------------------- e) Date of the 1 June 2017 transaction --- --------------------- -------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- -------------------------------------- 1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------- a) Name Koert Hendrik S Pretorius --- --------------------- -------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------- a) Position Chief Executive Officer - Mediclinic / status Southern Africa --- --------------------- -------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- -------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------- a) Name Mediclinic International plc --- --------------------- -------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- -------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------- a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- -------------------------------------- b) Nature of Award over ordinary shares in the transaction Mediclinic International plc granted under the Company's Long Term Incentive Plan --- --------------------- -------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) ---------- ---------- Nil cost 26,691 ---------- ---------- --- --------------------- -------------------------------------- d) Aggregated information Aggregated volume 26,691 Price ZAR0.00 --- --------------------- -------------------------------------- e) Date of the 1 June 2017 transaction --- --------------------- -------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- -------------------------------------- 1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------- a) Name David J Hadley --- --------------------- -------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------- a) Position Chief Executive Officer - Mediclinic / status Middle East --- --------------------- -------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- -------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------- a) Name Mediclinic International plc --- --------------------- -------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- -------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------- a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- -------------------------------------- b) Nature of Award over ordinary shares in the transaction Mediclinic International plc granted under the Company's Long Term Incentive Plan --- --------------------- -------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) ---------- ---------- Nil cost 18,397 ---------- ---------- --- --------------------- -------------------------------------- d) Aggregated information Aggregated volume 18,397 Price ZAR0.00 --- --------------------- -------------------------------------- e) Date of the 1 June 2017 transaction --- --------------------- -------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- -------------------------------------- 1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------- a) Name Dr Thorsten Ole Wiesinger --- --------------------- -------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------- a) Position Chief Executive Officer - Hirslanden / status --- --------------------- -------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- -------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------- a) Name Mediclinic International plc --- --------------------- -------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- -------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------- a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- -------------------------------------- b) Nature of Award over ordinary shares in the transaction Mediclinic International plc granted under the Company's Long Term Incentive Plan --- --------------------- -------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) ---------- ---------- Nil cost 22,350 ---------- ---------- --- --------------------- -------------------------------------- d) Aggregated information Aggregated volume 22,350 Price ZAR0.00 --- --------------------- -------------------------------------- e) Date of the 1 June 2017 transaction --- --------------------- -------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- --------------------------------------
About Mediclinic International plc
Mediclinic is an international private healthcare group with operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a LSE listed and UK-based private healthcare group.
Mediclinic comprises 74 hospitals and 37 clinics. Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 000 inpatient beds in total; Hirslanden operates 16 private acute care facilities and 4 clinics in Switzerland with more than 1 600 inpatient beds; and Mediclinic Middle East operates 6 hospitals and 31 clinics with more than 700 inpatient beds in the United Arab Emirates.
During February 2016, the combination of the Company (previously named Al Noor Hospitals Group plc), with operations mainly in Abu Dhabi in the United Arab Emirates, and Mediclinic International Limited was completed. Mediclinic International Limited was a South African based international private healthcare group founded in 1983 and listed on the JSE, the South African stock exchange, since 1986, with operations in South Africa, Namibia, Switzerland and the United Arab Emirates (mainly in Dubai). The combination resulted in the renaming of the enlarged group to Mediclinic International plc.
Mediclinic has a primary listing on the Main Market of the LSE, with secondary listings on the JSE in South Africa and the NSX in Namibia.
For further information, please contact:
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott (UK)
+44 (0)20 3727 1000
Frank Ford (South Africa)
+27 (0)21 487 9000
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBSGDLLDGBGRD
(END) Dow Jones Newswires
June 02, 2017 11:00 ET (15:00 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions